182 related articles for article (PubMed ID: 8400145)
1. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas.
Birchmeier W; Weidner KM; Hülsken J; Behrens J
Semin Cancer Biol; 1993 Aug; 4(4):231-9. PubMed ID: 8400145
[TBL] [Abstract][Full Text] [Related]
2. Molecular aspects of the loss of cell adhesion and gain of invasiveness in carcinomas.
Birchmeier W
Princess Takamatsu Symp; 1994; 24():214-32. PubMed ID: 8983077
[TBL] [Abstract][Full Text] [Related]
3. Adherens junction proteins in tumour progression.
Birchmeier W; Hülsken J; Behrens J
Cancer Surv; 1995; 24():129-40. PubMed ID: 7553658
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells.
Birchmeier W; Weidner KM; Behrens J
J Cell Sci Suppl; 1993; 17():159-64. PubMed ID: 8144693
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the role of cadherin in regulating cell adhesion during sea urchin development.
Miller JR; McClay DR
Dev Biol; 1997 Dec; 192(2):323-39. PubMed ID: 9441671
[TBL] [Abstract][Full Text] [Related]
6. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness.
Birchmeier W; Behrens J
Biochim Biophys Acta; 1994 May; 1198(1):11-26. PubMed ID: 8199193
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin as an invasion suppressor.
Birchmeier W; Hülsken J; Behrens J
Ciba Found Symp; 1995; 189():124-36; discussion 136-41, 174-6. PubMed ID: 7587628
[TBL] [Abstract][Full Text] [Related]
8. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
11. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma.
Van Marck V; Stove C; Van Den Bossche K; Stove V; Paredes J; Vander Haeghen Y; Bracke M
Cancer Res; 2005 Oct; 65(19):8774-83. PubMed ID: 16204047
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
[TBL] [Abstract][Full Text] [Related]
13. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.
Shtutman M; Levina E; Ohouo P; Baig M; Roninson IB
Cancer Res; 2006 Dec; 66(23):11370-80. PubMed ID: 17145883
[TBL] [Abstract][Full Text] [Related]
14. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells.
Miyaki M; Tanaka K; Kikuchi-Yanoshita R; Muraoka M; Konishi M; Takeichi M
Oncogene; 1995 Dec; 11(12):2547-52. PubMed ID: 8545111
[TBL] [Abstract][Full Text] [Related]
15. H-cadherin expression reduces invasion of malignant melanoma.
Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
[TBL] [Abstract][Full Text] [Related]
16. Modulation of E-cadherin localization in cells expressing wild-type E1A 12S or hypertransforming mutants.
Gopalakrishnan S; Quinlan MP
Cell Growth Differ; 1995 Aug; 6(8):985-98. PubMed ID: 8547227
[TBL] [Abstract][Full Text] [Related]
17. Molecular aspects of adhesion-epigenetic mechanisms for inactivation of the E-Cadherin-mediated cell adhesion system in cancers.
Hirohashi S
Verh Dtsch Ges Pathol; 2000; 84():28-32. PubMed ID: 11217445
[TBL] [Abstract][Full Text] [Related]
18. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
20. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F
Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
